Based on the findings that SLC25A11 expression is associated with clinical stage and histologic grade in liver cancer, we postulate that by stabilizing the mitochondrial membrane and maintaining sufficient mtGSH to withstand hypoxia-induced ROS production and cell apoptosis, SLC25A11 improves cell growth and tumor progression. The gene discussed is SLC25A11; the disease is neoplasm.